Go BACK

OUH STUDIES

Studies currently being run within Oxford University Hospitals NHS Foundation Trust.

Showing 671 - 680 of 742 studies

Phase Ia, first in human trial evaluating BI 1703880, a non-CDN STING agonist, in combination with ezabenlimab in solid tumors

Oxford Orthopaedic Research Database (ORD)

Understanding Inflammatory Fibrosis in Early Adhesive Capsulitis (FreeCap)

Single cellular profiling of renal disease: The Oxford Kidney Pathology Atlas

Cancer and neoplasms

CO43805 - A PHASE Ib, OPEN-LABEL, MULTICENTER STUDY EVALUATING THE SAFETY, PHARMACOKINETICS, AND EFFICACY OF MOSUNETUZUMAB OR GLOFITAMAB IN COMBINATION WITH CC-220 AND CC-99282 IN PATIENTS WITH B-CELL NON-HODGKIN LYMPHOMA

Respiratory

A Randomized, Double-Blind, Placebo controlled Study Assessing the Long-term Effect of Dupilumab on Prevention of Lung Function Decline in Patients with Uncontrolled Moderate to Severe Asthma (LPS16676 (ATLAS))

Neurological

A randomized, double-blind, placebo controlled, multicenter, phase 3, pivotal study with an open-label extension period to evaluate the efficacy and safety of rozanolixizumab in adult participants with myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease (MOG-AD) (MOG001)

Characterising the developmental origins in the pathogenesis of mesenchymal tumours of the central nervous system (STEMS)

Pilot study of the acceptability and feasibility of a 360-degree immersive PET/CT suite video tour intervention for the reduction of anxiety in PET/CT patients

The creation of a national UK database for patients with all myasthenic syndromes under NHS hospital care using Research Electronic Data Capture (REDCap)